G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2002
11/28/2002	WO2002095395A2 Benzophenone-linked crf and crf-like peptides for covalent labeling of corticotropin-releasing factor (crf) binding protein
11/28/2002	WO2002095394A2 Method for analyzing a biological sample
11/28/2002	WO2002095391A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	WO2002095389A2 Method and detector for detecting gases
11/28/2002	WO2002095387A1 Electrode system for electrochemical sensor
11/28/2002	WO2002095385A1 Biosensor
11/28/2002	WO2002095380A2 Method for determining a physical mass changing event
11/28/2002	WO2002095375A1 Semen analysis
11/28/2002	WO2002095369A1 Method and device for determining the permeation of a barrier layer
11/28/2002	WO2002095365A2 Method for determining a mass changing event
11/28/2002	WO2002095363A2 Methods for attenuation of virulence in bacteria
11/28/2002	WO2002095361A2 Identification of anti-protozoal agents
11/28/2002	WO2002095359A2 Method and apparatus for detecting illicit substances
11/28/2002	WO2002095356A2 Methods and compositions for analyzing proteins
11/28/2002	WO2002095355A2 Electrochemical method for high-throughput screening of minute quantities of candidate compounds
11/28/2002	WO2002095354A2 Methods and labeled molecules for determining ligand binding to steroid receptors
11/28/2002	WO2002095099A1 Noncovalent sidewall functionalization of carbon nanotubes
11/28/2002	WO2002095074A1 Foot and mouth disease virus diagnostic and methods
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095063A1 Pyruvate-kinase as a novel target molecule
11/28/2002	WO2002095061A1 Methods of screening test substances for treating or preventing diseases involving an oxidative stress
11/28/2002	WO2002095060A2 Determining endometrial status by testing menstruation tissue
11/28/2002	WO2002095059A2 Selection of target sites for antisense attack of rna
11/28/2002	WO2002095058A2 Emission ratiometric indicators of phosphorylation
11/28/2002	WO2002095054A2 Method of determining protein interaction inhibitors
11/28/2002	WO2002095036A2 A novel intein and uses thereof
11/28/2002	WO2002095034A2 A retinoic acid metabolizing cytochrome p450
11/28/2002	WO2002095030A2 Modulation of cd200 receptors
11/28/2002	WO2002095028A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria
11/28/2002	WO2002095020A1 A gene and uses therefor
11/28/2002	WO2002095017A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002	WO2002095012A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/28/2002	WO2002095009A2 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
11/28/2002	WO2002095003A2 Phytases, nucleic acids encoding them and methods for making and using them
11/28/2002	WO2002094998A2 Analyzing phosphorylated proteins
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	WO2002094990A2 Receptors and membrane-associated proteins
11/28/2002	WO2002094985A2 Beta-secretase substrates and uses thereof
11/28/2002	WO2002094981A2 Method of identifying peptides capable of binding to mhc molecules, peptides identified thereby and their uses
11/28/2002	WO2002094976A2 Identification of antimicrobial agents
11/28/2002	WO2002094881A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002	WO2002094878A1 Hevein-binding monoclonal antibodies
11/28/2002	WO2002094876A2 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	WO2002094873A2 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use
11/28/2002	WO2002094865A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology
11/28/2002	WO2002094864A2 Human cdnas and proteins and uses thereof
11/28/2002	WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002	WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	WO2002094780A2 Kinases and phosphatases
11/28/2002	WO2002094777A2 Methods of detecting protein arginine methyltransferase, and uses related thereto
11/28/2002	WO2002094672A1 Integrity indicator means provides visible change
11/28/2002	WO2002094439A2 System for cellular storage and genetic information retrieval
11/28/2002	WO2002094378A2 Increased functional activity and/or expression of abc transporters protects against the loss of dopamine neurons associated with parkinson's disease
11/28/2002	WO2002094314A1 Tsg101 as inhibitor of hiv production
11/28/2002	WO2002094307A1 Yin yang-1
11/28/2002	WO2002094287A2 Identifying parasitic fungi of the organism, and treatment thereof
11/28/2002	WO2002094259A1 Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation
11/28/2002	WO2002094248A2 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample
11/28/2002	WO2002094195A2 Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents
11/28/2002	WO2002094194A2 Compositions and methods for inhibiting metastasis
11/28/2002	WO2002094192A2 Antibodies against tumor necrosis factor delta (april)
11/28/2002	WO2002094185A2 Conjugates and compositions for cellular delivery
11/28/2002	WO2002094104A1 A urine collection device
11/28/2002	WO2002094092A1 Body fluid test apparatus with detachably mounted portable tester
11/28/2002	WO2002094084A2 Bmpr1a involvement in juvenile polyposis
11/28/2002	WO2002094083A2 Facile diagnosis and monitoring of pneumocystis carinii infection
11/28/2002	WO2002094009A2 Methods for selecting and producing animals having a predicted level of immune response
11/28/2002	WO2002083712A8 Transporters and ion channels
11/28/2002	WO2002078835A3 Substrates, preparation and use
11/28/2002	WO2002077245A9 Assay for drug-induced recoding
11/28/2002	WO2002075257A3 Enhanced triaxial tester with volume change device for measurement of flow properties of dry particulate systems under low confining pressures
11/28/2002	WO2002073228A3 Method for high resolution magnetic resonance analysis using magic angle technique
11/28/2002	WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002068606A3 Methods for the identification of herbicides and the modulation of plant growth
11/28/2002	WO2002066963A3 Method for detecting tse-induced modifications in the human and animal body
11/28/2002	WO2002065115A3 Device and method for detecting the presence of an analyte
11/28/2002	WO2002065092A9 Devices and methods for high throughput patch clamp assays
11/28/2002	WO2002065087A3 Biological fluid analysis device
11/28/2002	WO2002061038A9 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
11/28/2002	WO2002057790A3 Methods and compositions for diagnosing and treating a subject having depression
11/28/2002	WO2002057743A3 Methods of analyzing and sorting one or more analytes
11/28/2002	WO2002057741A3 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
11/28/2002	WO2002055989A3 Stable isotope, site-specific mass tagging for protein identification
11/28/2002	WO2002054065A3 Reversible mhc multimer staining for functional purification of antigen-specific t cells
11/28/2002	WO2002050529A9 Acoustic method for estimating mechanical properties of a material and apparatus therefor
11/28/2002	WO2002046718A3 Method of testing adequacy of specimen cells
11/28/2002	WO2002042766A3 A system and method for investigating the effect of chemical and other factors on cell movement
11/28/2002	WO2002039115A3 Detection of allergen-associated materials
11/28/2002	WO2002036733A3 Cd36 as a heat shock protein receptor and uses thereof
11/28/2002	WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002	WO2002032936A9 E. histolytica-specific antibodies and clinical uses thereof
11/28/2002	WO2002024924A3 Protein phosphatases
11/28/2002	WO2002010769A3 Identification of new therapeutic targets for modulating bile acid synthesis
11/28/2002	WO2002010754A3 Assay apparatus
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2001098528A3 Method for detecting cytosine methylations
11/28/2002	WO2001098360A3 Gp354 nucleic acids and polypeptides
11/28/2002	WO2001088543A3 Methods and compositions for diagnosing chronic immune disease
11/28/2002	WO2001075443A3 Method and reagents for investigating functional molecular interactions

1 ... 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 ... 3937